Product Liability Lawyer representing plaintiffs nationwide in Pharmaceutical Litigation and drug injury cases

.avif)



Thank you for considering The Lyon Firm. At this time, we are not accepting plaintiffs related to this specific consumer issue. However, if you would like to be contacted in the future, please complete the contact form. By completing the form you will be contacted if the Firm begins accepting new cases on this matter, and you will also be included in firm news alerts related to important consumer safety and privacy issues to help keep you informed about related issues.
After numerous high-profile stories of patients injuring themselves and others while taking Ambien, Lunesta and other sleep aid drugs, the risks are well-known. However, doctors continue to prescribe the drugs, and drug manufacturers continue to market and distribute them.
The U.S. Food and Drug Administration (FDA) announced a new boxed warning on some prescription insomnia drugs to better ensure patients are aware of the known drug risks. Ambien injury and related deaths are rare, though have occurred enough for the FDA to step in and issue an added warning.
Prescriptions for sleeping pills in the U.S. total more than 20 million. The FDA has warned of odd sleeping behavior since 2007, mostly from patients taking Ambien, the first of the insomnia drugs.
Patients on Ambien, Lunesta and Sonata have reported sleepwalking, sleep driving and engaging in other perilous activities like operating machinery. The black box warnings are now required for the following sleep drugs:
Joe Lyon is a highly-rated Cincinnati Drug Injury Attorney and Ohio product liability lawyer reviewing Ambien injury lawsuits and sleep drug accidents for plaintiffs nationwide.
Millions of Americans suffer from sleep issues and insomnia. Many wish to alleviate their problems with sleep aid drugs like Ambien, Sonata and Lunesta. But patients have not been properly warned by either doctors or drug companies about the risks these medications carry.
Even with new FDA boxed warnings, the risks still exist. A warning, after all, is not going to curtail what happens after the drug is ingested. But for liability reasons, drug companies feel the warning is a step in the right direction.
The Lyon Firm is committed to protecting consumers and holding drug companies responsible for the pharmaceuticals they market to the public. Sleep aid drugs are helpful, there is no doubt. But are they worth the risks of injury and accidents? This is a troubling question attorneys have had to ask in Ambien injury lawsuits and following sleep drug accidents.
Sleep drug accidents can occur after the first dose or after a long period of treatment. Patients without any history of sleepwalking have been reported to have been active while sleeping, even while taking small doses of the Ambien, Sonata or Lunesta. It is critical to know of these risks before taking the insomnia drugs. Common side effects of Ambien and other Z-drugs include:
In addition to the new boxed warning, the FDA is requiring an added warning to avoid prescribing these medicines in patients who have experienced complex sleep behavior episodes. The association between insomnia drugs and complex sleep behaviors that can lead to injury and deaths is included in the label warning. Ambien injury lawsuits and consumer safety advocates argue the risks of such drugs are understated.
In the FDA Adverse Event Reporting System, there are 46 reports of non-fatal serious injuries, including accidental overdoses, falls, burns, near-drowning, exposure to extreme cold temperatures leading to loss of limb or near death, self-inflicted gunshot wounds and apparent suicide attempts. There have been 20 deaths reported from carbon monoxide poisoning, drowning, fatal falls, hypothermia, and motor vehicle accidents.

.jpg)
By taking the initiative and filing drug injury lawsuits, plaintiffs can receive proper compensation and hold a corporation accountable for their negligent actions. Consumer safety depends largely on making sure companies operate within the law and within ethical boundaries.
Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there: